Gatti, M.; Giannella, M.; Rinaldi, M.; Gaibani, P.; Viale, P.; Pea, F.
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia. Antibiotics 2022, 11, 1739.
https://doi.org/10.3390/antibiotics11121739
AMA Style
Gatti M, Giannella M, Rinaldi M, Gaibani P, Viale P, Pea F.
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia. Antibiotics. 2022; 11(12):1739.
https://doi.org/10.3390/antibiotics11121739
Chicago/Turabian Style
Gatti, Milo, Maddalena Giannella, Matteo Rinaldi, Paolo Gaibani, Pierluigi Viale, and Federico Pea.
2022. "Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia" Antibiotics 11, no. 12: 1739.
https://doi.org/10.3390/antibiotics11121739
APA Style
Gatti, M., Giannella, M., Rinaldi, M., Gaibani, P., Viale, P., & Pea, F.
(2022). Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia. Antibiotics, 11(12), 1739.
https://doi.org/10.3390/antibiotics11121739
